Scott A. Smith is the chief executive officer of Viatris and is leading the execution of Phase 2 of the company’s strategic plan designed to guide Viatris into a period of renewed growth.
Career Highlights:
Before becoming Viatris’ CEO, Mr. Smith served as President of BioAtla, Inc., a global biotechnology company focused on the development of Conditionally Active BiologicsTM (CAB) antibody therapeutics, following serving as President and Chief Operating Officer at Celgene Corporation, where he rose up the ranks from SVP and Global Head of Immunology, and President of Inflammation and Immunology.
Key Skills and Experience:
Mr. Smith’s qualifications to serve on the Board include, among others, his experience regarding public company management, corporate governance, global business, healthcare industry, risk oversight and compliance, and strategy and M&A acquired during his more than 35 years in the healthcare industry, which has resulted in him possessing vast global commercial and pharmaceutical expertise and a proven ability to build, grow and manage large complex organizations utilizing his substantial experience in developing and executing regulatory, clinical, and business development strategies as displayed by time at BioAtla, where he built a clinical development structure that moved multiple assets from investigational new drug applications into late stage clinical development drove the company’s long-term strategic operational plan and led all business development activities and, prior to that, his time at Celgene where he led the company’s oncology, inflammation and immunology franchise, commercial operations and clinical development. Mr. Smith also brings finance, accounting and capital markets and human capital management experience to the Board.
Other Current Public Company Boards:
- BioAtla, Inc.
Former Public Company Boards:
- Apexigen, Inc.
- Titan Pharmaceuticals, Inc.
Former Private Company Boards:
- Triumvira Immunologics Inc., Chairman
- Refuge Biotechnologies, Inc.
- F-star Therapeutics, Inc., Chairman